尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the full record of transactions filed by Buthman Mark A, Director. Officer active across 3 companies, notably West Pharmaceutical Services INC. Aggregated, 10 disclosures have been logged. Activity tracked since 12 May 2021. The latest transaction was disclosed on 8 May 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 条申报中的 10 条
Mark A. Buthman is a Board Member at WEST PHARMACEUTICAL SERVICES INC and IDEX CORP /DE/. In his role, Mark participates in overseeing operations and developing strategies to enhance the companies' performance. His experience in the pharmaceutical and industrial services sectors is an asset to the boards.